Carcinogenesis Advance Access published online on January 19, 2008
Carcinogenesis, doi:10.1093/carcin/bgn003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Activation of RON Differentially Regulates Claudin Expression and Localization: Role of Claudin-1 in RON-Mediated Epithelial Cell Motility
1 Laboratory of Cancer Biology and Therapeutics, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P. R. China 310003
2 Cancer Biology Center and Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center School of Pharmacy, Amarillo, TX 79106, USA
* To whom correspondence should be addressed: Email: minghai.wang{at}ttuhsc.edu.
Claudins are integral membrane proteins essential in tight junction formation and function. Altered expression of claudins has been implicated in epithelial malignant transformation. We report here that activation of RON differentially regulates tight junction function and claudin expression. In Martin-Darby canine kidney (MDCK) cells, MSP-induced RON activation or expression of constitutively active variant RON160 significantly disrupted cellular tight junctions and reduced transepithelial electric resistance. These changes were featured by diminished claudin-1 expression and redistribution of claudin-3 and 4 into cytoplasmic compartments. The inhibition of claudin-1 was also seen in breast cancer T-47D cells. By analyzing the signaling events, we found that activation of the Erk1/2 pathway is required for RON-mediated inhibition of claudin-1 expression and redistribution of claudin-3 and 4. Results from luciferase reporter assays showed that inhibition is acted at the transcriptional levels because RON activation decreases claudin-1 promoter activities and increases transcriptional repressor Snail-1 expression. Functional analysis further revealed that reduced claudin-1 expression is linked to increased motilities of MDCK and T-47D cells as evident in cell migration and wound healing assays. Forced expression of claudin-1 prevented RON-mediated cell migration and restored cell morphologies to their original epithelial appearance. In conclusion, RON activation differentially regulates claudin expression in epithelial cells. Inhibition of claudin-1 expression may represent a novel mechanism that contributes to RON-mediated invasive activities leading to increased tumor malignancy.
Key Words: receptor tyrosine kinase tight junction claudins cell migration breast cancer
Received September 3, 2007; revised December 13, 2007; accepted December 25, 2007.